Call
Completed
QBR completed
Sep 16, 2025 03:27 PM
QBR Emory and UTAK
Introduction and account management changes @ 1:00
Andrew Hartmann from UTAK Laboratories introduces himself as the new account manager for Emory. He explains that UTAK is making changes to provide better service, including more frequent manufacturing of stock products to ensure longer expiration dates.
Feedback on product expiration and lot changes @ 2:31
Andrew discusses customer feedback about short expiration dates on UTAK's stock products. To address this, UTAK is making smaller, more frequent batches so customers are less likely to receive the same lot number when reordering. He suggests Emory may be interested in a custom product with a 2-year supply.
Customer satisfaction and feedback @ 5:38
Andrew asks Willa to rate UTAK on a scale of 1-10 and inquires about any challenges or concerns with UTAK's pricing, support, and resources. Willa provides generally positive feedback, noting some past supply chain issues that UTAK has resolved.
Custom product design and quoting @ 9:52
Andrew explains the process for Emory to design a custom UTAK product, including a 5-question survey he will send over email. He offers to work with Emory to get an initial quote and then finalize the product details.
UTAK's custom product capabilities @ 10:35
Andrew highlights UTAK's ability to create custom controls for a wide range of analytes beyond just immunosuppressants, including hormones, drugs, and other specialized tests. He inquires about Emory's current in-house testing and use of other vendors' controls.
Closing and next steps @ 15:13
Andrew asks if there is anything else he can do for Emory and inquires about potential opportunities to expand UTAK's business within the organization. He offers to send Emory's contact information a UTAK product catalog to share with other divisions.